Home > Financial Ratios > JUBILANT PHARMOVA

JUBILANT PHARMOVA
Core EBITDA Growth

    Back to All Ratios
JUBILANT PHARMOVA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for JUBILANT PHARMOVA
Please provide your vote to see the results

JUBILANT PHARMOVA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 26.9219.03-30.24-17.43-10.80

What is the latest Core EBITDA Growth ratio of JUBILANT PHARMOVA ?

The latest Core EBITDA Growth ratio of JUBILANT PHARMOVA is 26.92 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202526.92
Mar202419.03
Mar2023-30.24
Mar2022-17.43
Mar2021-10.80

How is Core EBITDA Growth of JUBILANT PHARMOVA Trending?

Years Core EBITDA Growth % Change
Mar2025 26.92
41.46
Mar2024 19.03
Positive
Mar2023 -30.24
Negative
Mar2022 -17.43
Negative
Mar2021 -10.8 -

Other Financial Ratios of JUBILANT PHARMOVA


Compare Core EBITDA Growth ratio of peers of JUBILANT PHARMOVA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JUBILANT PHARMOVA ₹17,649.6 Cr -1.6% 2.7% -0.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,077.0 Cr 2.8% 6.3% -1.1% Stock Analytics
DIVIS LABORATORIES ₹171,324.0 Cr -2.1% -2.5% 12.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,235.0 Cr -2.5% 4.2% 21.5% Stock Analytics
CIPLA ₹123,294.0 Cr 0% -3.3% 0.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,336.0 Cr 1.3% -0.5% -0.2% Stock Analytics


JUBILANT PHARMOVA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JUBILANT PHARMOVA

-1.6%

2.7%

-0.8%

SENSEX

0.9%

2.1%

8.3%


You may also like the below Video Courses